1 Department of Internal Medicine, Diabetes and Metabolic Diseases of Medical Clinic B, France
2 Faculty of Medicine of Strasbourg, France
3 Department of Endocrinology and Diabetology of Medical Clinic B, France
4 Department of Internal Medicine, Geriatrics and Therapeutics, France
5 Predimed Technology, France
6 Department of Physiology and Functional Explorations, France
7 Center of Expertise for Information and Communication Technologies for Autonomy (CENTICH), France
8 Research team EA 4662 Nanomedicine, Imaging & Therapeutics, France
*Corresponding author: Emmanuel Andrès, Department of Internal Medicine, Diabetes and Metabolic Diseases of Medical Clinic B, Strasbourg University Hospitals, 1, Hospital gate, 67091 Strasbourg cedex France
Submission: November 27, 2018;Published: January 03, 2019
Background: This is a narrative review of remote monitoring (telemedicine) projects within the field of type 1 and type 2 diabetes, with special attention placed on telemedicine 2.0 projects and studies.
Material and method: A literature search were performed using the PubMed database of US National Library of Medicine, along with Scholar Google. Textbooks on telemedicine and e-Health, from the American Diabetes Association (ADA) and the European Association for Study the Diabetes (EASD), as well as information from international meetings and commercial sites on the Web were used.
Result: Since the beginning of the 1990’s, several telemedicine projects and studies focused on type 1 and type 2 diabetes have been developed. Mainly, these projects and studies show that telemonitoring diabetic result in: improved blood glucose control; a significant reduction in HbA1c; improved patient ownership of the disease; greater patient adherence to therapeutic and hygiene-dietary measures; positive impact on co-morbidities (hypertension, weight, dyslipidemia); improved quality of life for patients; and at least good patient receptivity and accountability. To date, the magnitude of its effects remains debatable, especially with the variation in patients’ characteristics (e.g. background, ability for self-management, medical condition), samples selection and approach for treatment of control groups. Over the last 5years, numerous telemedicine projects based on connected objects and new information and communication technologies (ICT) (elements defining telemedicine 2.0) have emerged or are still under development. Two examples are the DIABETe and Telesage telemonitoring project which perfectly fits within the telemedicine 2.0 framework, being the firsts to include artificial intelligence with MyPrediTM and DiabeoTM (AI).
Keywords: Telemedicine; Telemonitoring; Artificial intelligence; Information and communication technology; Web; Diabetes; Heart failure; Chronic diseaseGet access to the full text of this article